Virtual Network's Login.
IT'S NOT TOO LATE TO REGISTER!
THE CONFERENCE STARTS THIS WEEK!
See you in London, UK
this Sunday, February 5th at 3pm GMT!
DO NOT MISS THE OPPORTUNITY,
REGISTER NOW FOR #ESHMICRO2023
The ESH team is looking forward to welcoming you!
About the programme:
This workshop offers highest-level science on the nature of the normal and malignant haemopoietic stem cell niche. It also aims to present strategies to target haematological cancers in their tumour microenvironment, thereby combining basic research efforts with possible clinical applications. It is designed to promote scientific interaction between participants from all over the world, involving junior and senior biologists and clinicians working in both the academic and industrial settings.
Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system.
This meeting will be valuable for you if you are looking for:
- Opportunity for lively discussions with leading and international experts, networking and forming of collaborations
- Informative and interactive Meet-the-expert-sessions
- Panel discussions with the experts and audience members
- Talks on novel data by outstanding speakers of international calibre
EHA-CME ACCREDITATION:
This Conference programme has been reviewed and approved by EBAH
for 16 CME-CPD credits.
MAIN SCIENTIFIC TOPICS:
• Normal Haemopoietic stem cell niche
• The bone marrow niche under stress and regeneration
• The bone marrow niche in myeloid malignancies
• Metabolism
• The bone marrow niche in lymphoid malignancies
• Immune cells and immunotherapy
• Preclinical and clinical studies to target bone marrow niche
LEARNING OBJECTIVES:
• Describe the impact of the niche on haematopoietic development
and ageing of haematopoietic stem cells
• Describe factors such as metabolism and inflammation/infection
influencing the niche and, consequently, haematopoietic stem cells
• The niche in myeloid and lymphoid malignancies
• The impact of immune cells and immunotherapy on the niche
• Concepts and strategies to target haematological malignancies in the niche
